FDA commissioner suggests RFK Jr. and Trump might compromise an agency ‘at peak performance’
The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s hostility to civil servants, Califf said. Trump has said he plans to give Kennedy, leader of the “Make America Healthy Again” movement, power over health care policy in his administration.
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out ...
Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...
Robert F. Kennedy Jr.’s selection Thursday as President-elect Donald Trump’s Health and Human Services secretary nominee sent shockwaves through Washington.
Kennedy has a history of vaccine disinformation and suggested a ban on fluoride in water and eliminating entire FDA ...
13hon MSN
FDA employees are reportedly eyeing exits amid talks of Robert F. Kennedy Jr. joining Trump's administration. Concerns extend ...
7don MSN
In an interview with NPR on Wednesday, Kennedy said Trump had already assigned him three tasks: to reduce the “corruption and ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback